Literature DB >> 16848812

Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution.

Lucia Malaguarnera1, Michelino Di Rosa, Michelino D Rosa, Anna M Zambito, Nicola dell'Ombra, Roberto Di Marco, Roberto D Marco, Mariano Malaguarnera.   

Abstract

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a liver disease characterized by steatosis and periportal and lobular inflammation. The molecular mechanisms involved in the anomalous behavior of liver cells have only partially been disclosed. Human Chitotriosidase (Chit) is a member of the chitinase family that it is mainly synthesized by activated macrophages. We investigated chitotriosidase gene expression in Kupffer cells to determine the potential implication of this enzyme in the inflammation and in the progression from uncomplicated steatosis to steatohepatitis with progressive fibrosis.
METHODS: Seventy-five liver biopsies from 40 subjects with NASH, 20 with simple steatosis, and 15 controls were used to detect CHIT expression, tumor necrosis factor-alpha (TNF-alpha), alpha-smooth muscle actin (alpha-SMA), and lipid peroxidation.
RESULTS: CHIT was expressed exclusively by Kupffer cells. The levels of CHIT expression were significantly higher in NASH patients than in simple steatosis patients and in the control group. In addition, we found that CHIT over-expression influenced hepatic stellate cells activation, as demonstrated by the significant correlation between CHIT and alpha-SMA expression in NASH patients. A significant correlation was observed also between CHIT, TNF-alpha and lipid peroxidation in both NASH and simple steatosis.
CONCLUSION: These results suggest that CHIT over-produced by Kupffer cells may contribute to the progression of hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848812     DOI: 10.1111/j.1572-0241.2006.00680.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

1.  Role of chitotriosidase (chitinase 1) under normal and disease conditions.

Authors:  Manasa Kanneganti; Alan Kamba; Emiko Mizoguchi
Journal:  J Epithel Biol Pharmacol       Date:  2012

2.  Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus.

Authors:  Alper Sonmez; Cem Haymana; Serkan Tapan; Umut Safer; Gurkan Celebi; Ozlem Ozturk; Halil Genc; Teoman Dogru; Ilker Tasci; Gokhan Erdem; Abdullah Taslipinar; Aydogan Aydogdu; Mahmut I Yilmaz; Ismail Kurt; Mustafa Kutlu
Journal:  Endocrine       Date:  2010-04-11       Impact factor: 3.633

3.  Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages.

Authors:  Michelino Di Rosa; Giulia Malaguarnera; Corinne De Gregorio; Filippo Drago; Lucia Malaguarnera
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

4.  3,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling.

Authors:  S Tomar; M Nagarkatti; P S Nagarkatti
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

5.  Chitotriosidase Expression during Monocyte-Derived Dendritic Cells Differentiation and Maturation.

Authors:  Michelino Di Rosa; Daniele Tibullo; Daniela Cambria; Gisella Distefano; Salvatore Saccone; Francesco Di Raimondo; Lucia Malaguarnera
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

Review 6.  Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Authors:  Katrin Eurich; Mayuko Segawa; Satoko Toei-Shimizu; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

7.  Human chitinases and chitinase-like proteins as indicators for inflammation and cancer.

Authors:  Julia Kzhyshkowska; Alexei Gratchev; Sergij Goerdt
Journal:  Biomark Insights       Date:  2007-05-03

Review 8.  Production of chitooligosaccharides and their potential applications in medicine.

Authors:  Berit B Aam; Ellinor B Heggset; Anne Line Norberg; Morten Sørlie; Kjell M Vårum; Vincent G H Eijsink
Journal:  Mar Drugs       Date:  2010-04-27       Impact factor: 5.118

Review 9.  Molecular mechanisms involved in NAFLD progression.

Authors:  Mariano Malaguarnera; Michelino Di Rosa; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2009-04-08       Impact factor: 4.599

10.  Effects of different therapeutic methods and typical recipes of Chinese medicine on activation of c-Jun N-terminal kinase in kupffer cells of rats with fatty liver disease.

Authors:  Qin-He Yang; Si-Ping Hu; Yu-Pei Zhang; Huan-Huan Ping; Huan-Wen Yang; Tong-Yan Chen; Hai-Tao Liu
Journal:  Chin J Integr Med       Date:  2012-09-11       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.